Cargando…
AAV Vector-Mediated Antibody Delivery (A-MAD) in the Central Nervous System
In the last four decades, monoclonal antibodies and their derivatives have emerged as a powerful class of therapeutics, largely due to their exquisite targeting specificity. Several clinical areas, most notably oncology and autoimmune disorders, have seen the successful introduction of monoclonal-ba...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9039256/ https://www.ncbi.nlm.nih.gov/pubmed/35493843 http://dx.doi.org/10.3389/fneur.2022.870799 |